Stocks
Cardiovascular Systems () EBITDA margin US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | LTM ? | ||||
| EBITDA margin, % | ? | -0.33% | -10.8% | -4.14% | -14.6% | -14.9% | ||
| Changes by years, y/y, % | -1pp | -10pp | +7pp | +4pp | ||||
Cardiovascular Systems. EBITDA margin, %
Cardiovascular Systems. EBITDA margin, changes, pp
Cardiovascular Systems () EBITDA margin US GAAP (quarter values) |
||||||||
| 2022Q1 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| EBITDA margin, % | ? | -17.1% | -16.5% | -14.6% | -15.1% | -13.3% | -14.9% | |
| Changes by years, y/y, % | -16pp | -9pp | -9pp | +2pp | ||||
| Changes by quarters, q/q, % | -5pp | +1pp | +2pp | 0pp | +2pp | |||
